• U Bion issued a correction to its stock option grant disclosure to reflect a share consolidation.
• Options granted revised to 58,233 common shares from 291,166.
• Exercise price adjusted to KRW 6,000 per share from KRW 1,200.
• Total options outstanding after the grant restated to 58,233 shares from 291,166.
• Per-recipient allocations restated to 38,822 shares for Oh Byeongju, 19,411 shares for Choi Youngjae.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. U Bion Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923000439), on September 23, 2026, and is solely responsible for the information contained therein.